Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer

NAPOLI-1 (NCT01494506) was a phase III study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy. This post hoc analysis of NAPOLI-1 aimed to develop a predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li-Tzong, Macarulla, Teresa, Blanc, Jean-Frédéric, Mirakhur, Beloo, de Jong, Floris A., Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721419/
https://www.ncbi.nlm.nih.gov/pubmed/31357748
http://dx.doi.org/10.3390/cancers11081068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721419/
https://www.ncbi.nlm.nih.gov/pubmed/31357748
http://dx.doi.org/10.3390/cancers11081068

Ejemplares similares